GB9606293D0 - Treatment of cancers and other tumours - Google Patents
Treatment of cancers and other tumoursInfo
- Publication number
- GB9606293D0 GB9606293D0 GBGB9606293.0A GB9606293A GB9606293D0 GB 9606293 D0 GB9606293 D0 GB 9606293D0 GB 9606293 A GB9606293 A GB 9606293A GB 9606293 D0 GB9606293 D0 GB 9606293D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- tumours
- cancers
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9606293.0A GB9606293D0 (en) | 1996-03-26 | 1996-03-26 | Treatment of cancers and other tumours |
AU21689/97A AU2168997A (en) | 1996-03-26 | 1997-03-26 | Use of heme oxygenase inhibitors to treat cancer |
PCT/GB1997/000844 WO1997035569A1 (en) | 1996-03-26 | 1997-03-26 | Use of heme oxygenase inhibitors to treat cancer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9606293.0A GB9606293D0 (en) | 1996-03-26 | 1996-03-26 | Treatment of cancers and other tumours |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9606293D0 true GB9606293D0 (en) | 1996-05-29 |
Family
ID=10791003
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB9606293.0A Pending GB9606293D0 (en) | 1996-03-26 | 1996-03-26 | Treatment of cancers and other tumours |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2168997A (en) |
GB (1) | GB9606293D0 (en) |
WO (1) | WO1997035569A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999004817A1 (en) * | 1997-07-25 | 1999-02-04 | Brigham & Women's Hospital, Inc. | Chemotherapy synergistic agent |
WO2007103427A2 (en) * | 2006-03-06 | 2007-09-13 | Wang Xiang H | Medical use of bilirubin and its structural analogues |
GB201120860D0 (en) | 2011-12-05 | 2012-01-18 | Cambridge Entpr Ltd | Cancer immunotherapy |
US10888569B1 (en) * | 2017-06-09 | 2021-01-12 | The University Of Chicago | Methods and compositions for treating cancer |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1989002269A1 (en) * | 1987-09-08 | 1989-03-23 | The Rockefeller University | Use of metalloporphyrins to reverse the toxic effect of tumor therapy |
US4960790A (en) * | 1989-03-09 | 1990-10-02 | University Of Kansas | Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof |
PL165249B1 (en) * | 1991-10-29 | 1994-11-30 | Wojskowa Akad Tech | Method op obtaining complex salts of hematporphyrine and its derivatives |
DE4305881C1 (en) * | 1993-02-26 | 1994-03-03 | Lohmann Therapie Syst Lts | Transdermal therapeutic system for topical and systemic application of active agents - includes cpd(s) from which nitrogen oxide is released by human or animal metabolism or cpds which release nitrogen oxide in organism |
-
1996
- 1996-03-26 GB GBGB9606293.0A patent/GB9606293D0/en active Pending
-
1997
- 1997-03-26 AU AU21689/97A patent/AU2168997A/en not_active Abandoned
- 1997-03-26 WO PCT/GB1997/000844 patent/WO1997035569A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1997035569A1 (en) | 1997-10-02 |
AU2168997A (en) | 1997-10-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0831904A4 (en) | Treatment and diagnosis of prostate cancer | |
ZA957483B (en) | Compounds and methods for the treatment of cancer | |
ZA979096B (en) | Viral and cancer treatment | |
HU9602965D0 (en) | Cancer treatment and metastasis prevention | |
EP0926955A4 (en) | Conjugates useful in the treatment of prostate cancer | |
PL335160A1 (en) | Treatment of hiv and carcinoma | |
EP0758196A4 (en) | Compositions and methods of treating tumors | |
HUP0004326A3 (en) | Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms | |
HK1024876A1 (en) | Conjugates useful in the treatment of prostate cancer | |
PL340604A1 (en) | Application of macrolydes in treating tumours and maculopathy | |
GB2318734B (en) | Methods of preventing breast cancer | |
AU4003597A (en) | Methods of diagnosing and treating cancer | |
IL114119A0 (en) | Compositions and methods for the treatment of tumors | |
HK1063004A1 (en) | Oxalatoplatin and 5-fluorouracil for combination therapy of cancer | |
GB9811598D0 (en) | Diagnosis and treatment of cancer | |
EP0907720A4 (en) | Combined radiotherapy and immunotherapy to treat cancer | |
GB9606293D0 (en) | Treatment of cancers and other tumours | |
GB9819999D0 (en) | Treatment of cancer | |
GB9812550D0 (en) | Tumour therapy and imaging | |
EP0929540A4 (en) | Antitumor compositions and methods of treatment | |
GB9423702D0 (en) | Diagnosis and treatment of tumours | |
EP0949916A4 (en) | Antitumor compositions and methods of treatment | |
GB9624800D0 (en) | Methods of preventing breast cancer | |
ZA937015B (en) | Treatment and diagnosis of cancer | |
SI0971585T1 (en) | Tetracycline compounds in the treatment of certain types of cancers |